Shanghai Allist Pharmaceuticals Co., Ltd.
688578
Rank in Stocks
#3127
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese... Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Share Price
$12.65
Market Cap
$5.69B
Change (1 day)
-0.05%
Change (1 year)
-14.35%
Country
CN
Trade Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
Category
Healthcare
P/E ratio for Shanghai Allist Pharmaceuticals Co., Ltd. (688578)
P/E ratio as of October 2026 TTM: 14.25
According to Shanghai Allist Pharmaceuticals Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 14.25. At the end of 2024 the company had a P/E ratio of 18.84.
P/E ratio history for Shanghai Allist Pharmaceuticals Co., Ltd. from 2017 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 14.25 | -33.63% |
| 2025 | 21.47 | 14.00% |
| 2024 | 18.84 | -35.34% |
| 2023 | 29.13 | -57.07% |
| 2022 | 67.86 | -91.01% |
| 2021 | 755.00 | -2,326.82% |
| 2020 | -33.90 | -3.25% |
| 2019 | -35.05 | 0.00% |
| 2018 | 0.00 | 0.00% |
| 2017 | 0.00 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 28.78 | 101.98% |
US
|
|
| -29.16 | -304.66% |
US
|
|
| -25.99 | -282.40% |
AU
|
|
| 17.49 | 22.73% |
BE
|
|
| 31.22 | 119.07% |
NL
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.